Christopher Frampton

Papers

Total Citations

H-Index

About

Professor Christopher Frampton is a distinguished biostatistician whose methodological expertise has profoundly shaped clinical research across multiple therapeutic areas. His primary contributions lie in the design and analysis of large-scale randomized controlled trials, particularly in surgical oncology and cardiovascular medicine. Frampton’s most notable work includes the Australasian Laparoscopic Colon Cancer Study (ALCCaS), a landmark non-inferiority trial comparing laparoscopic versus open surgery for colon cancer—a rare and complex multicenter surgical RCT that has informed global treatment guidelines. Beyond colorectal surgery, he has been instrumental in trials evaluating novel interventions for heart failure, diabetes, and respiratory diseases, often serving as the lead statistician ensuring rigorous methodology and robust data interpretation. With over 800 publications and citation counts exceeding 20,000, his work has directly influenced evidence-based practice. Frampton is also recognized for his collaborative leadership, mentoring generations of clinician-researchers, and his role in establishing New Zealand’s reputation for high-quality clinical trials. His career exemplifies how meticulous statistical science can translate into tangible improvements in patient outcomes.